Brightlands Venture Partners, also known as BVP, is an independent venture capital fund manager headquartered in Geleen, Netherlands. Established in 2004, the firm focuses on investing in innovative startups and scale-ups that develop breakthrough technologies addressing global challenges in health, agrifood, and renewable chemistry.
BVP manages four venture capital funds with a total committed capital of approximately €120 million. These include Limburg Ventures (founded 2004), Chemelot Ventures (2014), Brightlands Agrifood Fund (2017), and BVP Fund IV (2021). The funds support companies connected to the Brightlands innovation campuses, providing capital, expertise, and access to research and industry networks.
The firm has backed more than 50 companies across Europe and the US, with a track record of successful exits. It emphasizes impact investing, targeting early-stage opportunities with strong growth potential and measurable societal benefits. BVP operates primarily in the Benelux region and Germany, leveraging its position within the Brightlands ecosystem to accelerate portfolio company development.
As a high-conviction investor, BVP partners closely with founders to translate scientific breakthroughs into scalable businesses, contributing to sustainable transitions in essential societal systems.
Official website: bvp.capital
chemXplore tracks active investment projects involving BVP, across sectors such as Basic Chemicals, Biobased & Circular, and Polymers.
BVP's role is mapped on each — as Investor / Financier.
